Strategic Investment in System1

Summary by AI BETAClose X

Brave Bison Group PLC has acquired a 28% stake in System1 Group plc through a share-for-share exchange with founder John Kearon and £1.3 million in on-market purchases, resulting in a blended acquisition price of 242 pence per System1 share, representing a 5.2x FY26e EV/EBITDA multiple. This strategic investment is expected to boost Brave Bison's adjusted profit after tax by approximately 5% on a pro-forma basis, with System1 projected to hold £12 million in net cash as of March 31, 2026. Following the admission of 9,810,504 new Brave Bison shares to trading on AIM on March 4, 2026, the company's total issued share capital will be 112,284,802 ordinary shares.

Disclaimer*

Brave Bison Group PLC
02 March 2026
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

2 March 2026

 

Brave Bison Group plc

 

("Brave Bison" or the "Company", together with its subsidiaries "the Group") 

 

Strategic Investment

 

Issue of Equity

 

and

 

Total Voting Rights

 

Strategic 28% investment in marketing effectiveness leader System1

 

Brave Bison supports the board's strategy

 

Brave Bison, the next-generation marketing and technology partner for global brands, is pleased to announce the acquisition of a 28% direct equity interest in System1 Group plc ("System1") by way of a share-for-share exchange with John Kearon, System1's founder and largest shareholder, and on-market purchases totalling £1.3 million (together the "Strategic Investment").

 

In exchange for his 2,919,793 ordinary shares in System1, John Kearon will be issued with 9,810,504 new ordinary shares in Brave Bison, representing 8.7% of the Group's enlarged issued share capital, at an issue price of 74 pence per new Brave Bison share (the "Issue Price"). John Kearon has agreed to an 18-month lock up period.

 

In addition, Brave Bison has acquired a further 628,111 shares for cash via on-market purchases for a total consideration of £1.3 million at a price of 210 pence per share.

 

Based on the Issue Price and on-market purchases, the blended price per System1 share acquired is 242 pence, representing an FY26e EV/EBITDA of 5.2x.

 

Under the equity method of accounting, the Strategic Investment is expected to increase Brave Bison adjusted profit after tax by approximately 5% on a pro-forma basis. Based on consensus estimates, System1 is expected to report net cash as at 31 March 2026 of approximately £12 million.

 

Brave Bison is supportive of the strategy presented by the board of System1 at the company's capital markets day in October 2025 and, where possible, intends to provide support in the execution of this plan.

 

System1 Summary Financials

 

£m, 31 March

FY23

FY24

FY25

FY26e(1)

Revenue

23.4

30.0

37.4

35.8

Adj. EBITDA

1.6

4.4

6.6

3.6

Net Cash(2)

5.7

9.6

12.9

12.2

 

(1) Company compiled consensus estimates: Singer Capital Markets, 20 January 2026 and Canaccord Genuity, 20 January 2026

(2) Excluding lease liabilities

 

John Kearon, Founder of System1, commented:

 

"I'm delighted to be rolling my equity interest in System1 into Brave Bison. I firmly believe that with Brave Bison's shared ambition, vision, and support, System1 will be best able to fulfil its growth potential and create a braver, brighter future."

 

About System1

 

System1 is a marketing effectiveness business that allows major brand advertisers to test marketing campaigns and product innovation through a purpose-built platform and data-led consultancy. Customers include Sky, Waitrose and Subway.

 

System1 was founded by John Kearon in 2006 and the company's flagship Test Your Ad is now one of the most respected creative testing platforms in the industry. Test Your Ad uses second-by-second emotional responses to score and rank creative campaigns against a database of over 120,000 adverts with over 18 million tracked emotional responses. Test Your Ad has grown from 81 customers in 2021 to 533 customers in 2025, and approximately 40% of System1's revenue is generated in the US.

 

Strategic Rationale

 

Shared customer needs and complimentary solutions

 

Brave Bison's mission to help businesses capitalise on the complexity of the modern marketing landscape aligns closely with System1's mission to make marketing more effective. In an increasingly fragmented, AI-accelerated and data-saturated environment, modern marketers face great difficulty in identifying the levers that truly drive growth.

 

With Brave Bison focused on orchestrating bespoke solutions across marketing consultancy, training and execution to capitalise on that complexity, System1 provides the behavioural science and predictive effectiveness framework that can ensure those decisions translate into measurable commercial impact.

 

Our two separate missions converge around a shared objective: enabling brands to make better decisions, deploy resources with greater confidence, and achieve measurable growth in an increasingly complex environment.

 

A unified and holistic view of marketing effectiveness for customers

 

System1's evidence-based principles of marketing effectiveness align directly with the marketing science foundations taught through the MiniMBA and delivered through Brave Bison's agency services, as is evidenced by a significant overlap across our existing customer bases.

 

Thought leadership as a commercial advantage

 

Brave Bison and System1 share a growth philosophy characterised by community, education and evidence-led thought leadership. Through MiniMBA founder Professor Mark Ritson, Brave Bison leverages one of the marketing industry's most respected voices to build credibility, deepen senior client relationships and create upstream commercial opportunity.

 

Similarly, System1 amplifies its effectiveness credentials through thought leaders such as John Kearon, Andrew Tindall (researcher and LinkedIn Top Voice), Orlando Wood (IPA Fellow, researcher and author) and Jon Evans (host of industry-leading podcast Uncensored CMO) to position the business at the forefront of the effectiveness debate. Both businesses have also seen significant success engaging and scaling loyal communities of marketers through their SocialMinds (Brave Bison) and Uncensored CMO (System1) podcasts.

 

In both cases, thought leaders are not just effective brand ambassadors but core drivers of demand generation, differentiation and trust.

 

Admission of new Ordinary Shares and Total Voting Rights

 

As a result of the Strategic Investment, application has been made for a total of 9,810,504 new Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on 4 March 2026 and the new Ordinary Shares will, on issue, rank pari passu in all respects with the Company's existing Ordinary Shares.

 

On Admission, the Company will have a total of 112,284,802 Ordinary Shares in issue. No Ordinary Shares are held in treasury. The figure of 112,284,802 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

For further information please contact:  

 

Brave Bison Group plc                                                                                 via Cavendish 

Oliver Green, Executive Chairman                                                           

Theo Green, Chief Growth Officer  

Philippa Norridge, Chief Financial Officer  

 

Cavendish Capital Markets                                                                                         Tel: +44 (0) 20 7220 0500 

Nominated Adviser & Joint Broker  

Ben Jeynes / Teddy Whiley / Elysia Bough - Corporate Finance 

Michael Johnson / Sunila de Silva - ECM

 

Singer Capital Markets                                                                                                 Tel: +44 (0) 20 7496 3000 

Joint Broker  

Alex Bond / Sara Hale

 

About Brave Bison 

 

Brave Bison is a media, marketing and technology partner for global brands. With operations across eight countries including the UK, US, India, Australia and Egypt, Brave Bison supports customers with marketing consultancy, execution and training services via a connected, AI-enabled operating model.

 

The company operates through three divisions: marketing consultancy, marketing training and sport and entertainment. The marketing consultancy division designs and deploys bespoke, insight-led and AI-enabled growth strategies for global brands and businesses including New Balance, Primark and Google via specialist agencies including SocialChain and MTM. The sport and entertainment division monetises content and scales communities for the biggest creators, teams and federations on the planet-from Real Madrid to the US Open. Finally, the marketing training division, MiniMBA, is an eLearning platform offering industry-leading MBA-level training in brand, marketing and business strategy for leading global enterprises such as Carlsberg, Nestlé and Salesforce.

 

Forward-looking Statements

 

This announcement regarding the Strategic Investment contains statements about Brave Bison and/or System1 that are or may be deemed to be forward-looking statements. Without limitation, any statements preceded or followed by or that include the words "targets", "plans", "believes", "expects", "aims", "intends", "hopes", "continues", "would", "could", "should", "will", "may", "anticipates", "estimates", "projects" or words or terms of similar substance or the negative thereof, are forward-looking statements. These forward-looking statements are not based on historical fact and are not guarantees of future performance. By their nature, such forward-looking statements involve known and unknown risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results to differ materially from those projected or implied in any forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond Brave Bison's ability to control or estimate precisely. These factors include, but are not limited to, changes in political and economic conditions, changes in levels of capital investment, success of business and operating initiatives, the impact of any acquisitions or similar transactions, changes in clients' strategies, changes in the regulatory environment and fluctuations of rates, and changes in tax rates. Except as expressly provided in this announcement, they have not been reviewed by the auditors of Brave Bison or System1. Neither Brave Bison, nor any of its respective members, associates or directors, officers, employees or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. Neither Brave Bison, nor any of its respective members, associates or directors, officers, employees or advisers assumes any obligation to update or correct the information contained in this announcement except as required by applicable law. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this announcement. Brave Bison disclaims any obligation to correct or update any forward-looking or other statements contained in this announcement, except as required by applicable law or by the rules of any competent regulatory authority, whether as a result of new information, future events or otherwise.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings